July 2, 2009 - The Centers for Medicare and Medicaid Services (CMS) today released its proposed 2010 Medicare physician fee schedule, which includes proposals to significantly cut payments for cardiovascular-related services, prompting a stern response from the American College of Cardiology (ACC). CMS projects the changes would reduce total Medicare payments to cardiology by 11 percent.

July 1, 2009 – Cardioxyl Pharmaceuticals Inc. announced today the initiation of a phase I/IIa dose-escalation study of lead drug candidate, CXL-1020, for the treatment of acute decompensated heart failure (ADHF).

July 1, 2009 - Radiologists can effectively lower the patient radiation dose by approximately 44 percent and improve vascular enhancement without deterioration of image quality, while screening for possible pulmonary emboli using pulmonary CT angiography, according to a study Brigham and Women's Hospital and Harvard Medical School, Boston, Mass., published in the June issue of the American Journal

July 1, 2009 - On Sept. 9, 2009, the American College of Radiology (ACR) will offer the inaugural Cardiac CT Certificate of Advanced Proficiency (CCT CoAP) Examination open to all physicians who meet the requisite eligibility requirements and professional experience qualifications.

June 30, 2009 - Stentys this week said it secured the second tranche of its series B financing, which will enable the company to obtain CE marking and begin European marketing of the first self-expanding stent platform for the treatment of myocardial infarction.

June 30, 2009 - Doctors at the Cedars-Sinai Heart Institute said today they completed the first procedure in which a patient's own heart tissue was used to grow specialized heart stem cells that were then injected back into the patient's heart in an effort to repair and regrow healthy muscle in a heart that had been injured by a heart attack.

June 29, 2009 – Cordex Pharma said today it successfully completed the production of the ATPace clinical trial material (CTM) in preparation for planned pivotal clinical trials. ATPace is a novel, proprietary, stable, injectable formulation of adenosine 5'-triphosphate (ATP) under development as a therapeutic and diagnostic drug for the management of cardiac arrhythmias, said the company.

June 29, 2009 – Last week’s death of Michael Jackson at the age of 50 underscores the tragedy of sudden cardiac arrest, which kills nearly 300,000 Americans each year and is the nation's leading cause of death, said Sudden Cardiac Arrest Association and the American Heart Association (AHA).